Incyte Corporation technical analysis
Technical analysis of Incyte Corporation (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Incyte Corporation
Incyte Corporation is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for oncological and hematological diseases, operating in the United States, Europe, Canada, and Japan. Its product portfolio includes approved treatments for conditions such as myelofibrosis, chronic myeloid leukemia, and certain lymphomas, as well as topical formulations and clinical-stage products for oncology and dermatological and autoimmune diseases.
Description generated automatically from public sources; it may be inaccurate or out of date.
Incyte Corporation: latest session data
Closing values for September 2, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
124.15 $
+2.87%
50 sessions
120.01 $
+6.42%
200 sessions
104.50 $
+22.21%
Session levels
s2
121.58
Support
s1
123.29
Support
pivot
124.22
Pivot
r1
125.93
Resistance
r2
126.86
Resistance
How to read it
In the September 2, 2026 session Incyte Corporation closed higher at 127.71 $, +2.16% versus the previous session.
The price sits above every moving average observed: +2.87% against the 21-session average, +6.42% against the 50 and +22.21% against the 200.
The 14-period RSI reads 59.6, in neutral territory.
MACD stands at 2.142 against a signal line at 2.496: the histogram is negative (−0.353).
ADX reads 22.4, indicating weak directionality.
Levels computed on the latest session place supports at 123.29 and 121.58 $ and resistances at 125.93 and 126.86 $, around a pivot of 124.22.
The average daily range (ATR) is 3.392 $, or 2.66% of price.
Turnover was 373.1K shares, 32% of the 20-session average.
Over the last twelve months the price ranged between 89.25 and 132.58 $, and today stands −3.67% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the INCY analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Incyte Corporation
How is Incyte Corporation analysed technically?
Technical analysis of Incyte Corporation is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Incyte Corporation?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Incyte Corporation?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Incyte Corporation it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.